Neutrophil chemotaxis pathway

The neutrophil chemotaxis pathway refers to the complex network of molecular signals and cellular processes that enable neutrophils—a type of white blood cell—to detect chemical gradients (chemoattractants) at sites of infection or injury and migrate directionally toward these signals. This process is essential for effective innate immune responses. Key components include G protein–coupled receptors such as formyl peptide receptors (FPRs), which sense bacterial peptides like N-formylmethionyl-leucyl phenylalanine (fMLF), as well as complement-derived chemoattractants like C5a, and specific chemokines such as IL‑8. Upon activation by these ligands, downstream signaling pathways regulate cytoskeletal rearrangement—primarily actin polymerization—and direct cell movement. Additional modulators include ATP-gated P2X1 ion channels that promote Rho kinase-dependent contraction necessary for efficient migration, and the NADPH oxidase complex whose generation of reactive oxygen species is critical for maintaining directional persistence during migration. Disruption in this pathway—whether through genetic defects affecting key enzymes like NADPH oxidase or pharmacological inhibition—can result in impaired host defense mechanisms, leading to diseases characterized by recurrent infections or dysregulated inflammation such as chronic granulomatous disease or antiphospholipid syndrome. While individual molecules within this pathway are considered therapeutic targets, the "neutrophil chemotaxis pathway" itself is a biological process rather accurate than a discrete druggable target.

Inhibition of glycolysis reduces neutrophil NETosis and chemotactic activity; Activation or inhibition of P2X1 ion channels modulates actomyosin contraction and cell movement; Inhibition of NADPH oxidase impairs reactive oxygen species production, affecting directionality and migration.